---
schema_version: "secwatch.filing_event.v1"
accession: "0001689548-22-000051"
form_type: "8-K"
ticker: "PRAX"
cik: "0001689548"
company_name: "Praxis Precision Medicines, Inc."
filed_at: "2022-05-23T23:59:59+00:00"
generated_at: "2026-06-25T08:16:41.393512+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Praxis Precision Medicines elects Jill DeSimone to Board as Class I director

## Summary
- Jill DeSimone elected to Board as Class I director effective May 23, 2022.
- Board determined DeSimone is independent under Nasdaq listing standards.
- DeSimone to receive compensation per company's Non-Employee Director Compensation Policy.
- No related person transactions or arrangements exist with DeSimone.
- DeSimone entered into standard indemnification agreement with the company.

## SEC filing metadata
- accession: 0001689548-22-000051
- form_type: 8-K
- ticker: PRAX
- cik: 0001689548
- company_name: Praxis Precision Medicines, Inc.
- filed_at: 2022-05-23T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1689548/000168954822000051/0001689548-22-000051-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1689548/000168954822000051/prax-20220521.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001689548-22-000051
- JSON: https://secwatch.observer/filing/0001689548-22-000051.json
- Plain text: https://secwatch.observer/filing/0001689548-22-000051.txt

## Key facts
- Executive change
  Jill DeSimone was elected as Class I director at Praxis Precision Medicines, Inc..
  - Action: elected
  - Role: Class I director
  source text: elected Jill DeSimone to the Board as a Class I director, effective May 23, 2022
  evidence_url: https://www.sec.gov/Archives/edgar/data/1689548/000168954822000051/0001689548-22-000051-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.